(1) Department of Surgery, Mayo Clinic, Rochester, MN, USA;(2) Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;(3) Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Abstract:
Background
Completion axillary lymph node dissection (CALND) is controversial in patients with sentinel lymph node (SLN) metastases ≤ 0.2 mm [N0 (i+)]. Our goal was to characterize patients with SLN isolated tumor cells regarding surgical management and axillary recurrence.